project id: TCGA-SARC; case submitter id: TCGA-X2-A95T; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.67; rna integrity number: 8.5; age at index: 49; days to birth: -18079; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1960; age at diagnosis: 18079; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1927.0; icd 10 code: C55; last known disease status: not reported; morphology: 8890/3; primary diagnosis: Leiomyosarcoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Uterus, NOS; synchronous malignancy: No; tissue or organ of origin: Uterus, NOS; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1598; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-X2-A95T-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0;